Study Stopped
Recruitment was not feasible at site.
Pressure injuRy preventiOn by inTermittent EleCtrical sTimulation
PROTECT
The PROTECT Study: Pressure injuRy preventiOn by inTermittent EleCtrical sTimulation
1 other identifier
interventional
4
1 country
1
Brief Summary
The proposed study assesses the superiority of IES supplementation to the standard of care alone (offloading pressure every two hours) in improving the prevention and treatment of sacral and ischial pressure injuries.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Feb 2021
Shorter than P25 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 26, 2020
CompletedFirst Posted
Study publicly available on registry
March 31, 2020
CompletedStudy Start
First participant enrolled
February 26, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 14, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 14, 2022
CompletedJanuary 11, 2023
March 1, 2020
1 year
March 26, 2020
January 10, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Clinical course of pressure injury over time
Chauhan Weighted Trajectory Analysis (CWTA) will be used to compare the morbidity associated with sacral and ischial pressure injuries through time. A one-sided Chauhan logrank test at a significance of 0.05 will be used to assess for superiority of the experimental arm over the control arm.
Patients will be assessed daily for pressure injury location and stage through treatment completion, an average of 14 days.
Secondary Outcomes (8)
Clinical course of pressure injury in subgroups
Patients will be assessed daily for pressure injury location and stage through treatment completion, an average of 14 days.
Kaplan-Meier Time-to-Event Analysis
Final analysis will be performed at end of study (expected completion 2 years)
Cox Regression Analysis
Final analysis will be performed at end of study (expected completion 2 years)
Observed Counts of Pressure Injuries
Final analysis will be performed at end of study (expected completion 2 years)
Onset Time
Final analysis will be performed at end of study (expected completion 2 years)
- +3 more secondary outcomes
Study Arms (2)
IES Device + Standard of Care
EXPERIMENTALIntermittent electrical stimulation system. Charged pulses will be administered to bilateral gluteus maximus through surface electrodes. Stimulation occurs at 30 Hz for 10s every 10 minutes. The intervention is administered 24/7 and added to the standard of care management. Standard of care is defined as turning the patient every two hours.
Standard of Care
ACTIVE COMPARATORStandard of care treatment for pressure injuries is turning the patient every two hours.
Interventions
The IES system is composed of a stimulator and self-adhesive surface gel electrodes.
Standard institutional practices for treating pressure injury.
Eligibility Criteria
You may qualify if:
- Modified Braden Scale score of 14 or less. The Modified Braden Scale score is calculated as follows:
- Braden Scale score (Ranges from 6 to 23)
- for Low Serum Albumin
- for Type II Diabetes
- Anticipated length of stay of at least 4 days
- BMI \< 35
- Participants capable of giving informed consent, or if appropriate, participants having an acceptable individual capable of giving consent on the participant's behalf.
You may not qualify if:
- Existing pressure injuries above Stage II and injuries classified as DTI or unstageable
- Neuromuscular blocking drugs \& myasthenia gravis: may prevent the ability of electrical stimulation to induce muscular contraction
- Unstable spinal, pelvic, or hip fractures that may be displaced by a forced contraction
- Rhabdomyolysis
- Use of a Pacemaker
- Skin breakdown over the gluteal regions that would preclude the use of surface electrodes.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AHS Cancer Control Albertalead
- Rehabtronicscollaborator
Study Sites (1)
Cross Cancer Institute
Edmonton, Alberta, T6G 1Z2, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 26, 2020
First Posted
March 31, 2020
Study Start
February 26, 2021
Primary Completion
March 14, 2022
Study Completion
March 14, 2022
Last Updated
January 11, 2023
Record last verified: 2020-03